tuberculosis
Conditions
Interventions
A cross-border TB patient Referral Mechanism: i) The pathway of the mechanism in Japan a) To make the mechanism publicly known through the home page of the Research Institute of Tuberculosis (RIT),
Sponsors
Research Institute of Tuberculosis (RIT), Japan Anti-Tuberculosis Association (JATA)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All of the TB patients including the latent TB infection patients who were born in either of the four countries, i.e., China, Viet Nam, the Philippines, South Korea, and Myanmar, are diagnosed from April 2019 till March 2012 in Japan, are willing to return back to their home country during the treatment, provide the informed consent form, and are 18 years old and above are eligible to be involved in the study.
Exclusion criteria
Exclusion criteria: All TB patients who do not fall in any of the criteria above.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TB treatment success rate (%) after return to the original home country | — |
Secondary
| Measure | Time frame |
|---|---|
| TB patient access rate (%) after return to the orignal home country | — |
Countries
Japan,Asia(except Japan)
Contacts
Public ContactOHKADO AKIHIRO
Research Institute of Tuberculosis (RIT), Japan Anti-Tuberculosis Association (JATA) Department of Epidemiology and Clinical Research
Outcome results
None listed